SDMA
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


SDMA
Description :
SDMA (Symmetric dimethylarginine) is an endogenous inhibitor of nitric oxide (NO) synthase activity. SDMA, a novel kidney biomarker, permits earlier diagnosis of kidney disease than traditional creatinine testing.Product Name Alternative :
Symmetric dimethylarginine; NG, NG'-Dimethyl-L-arginineUNSPSC :
12352211Hazard Statement :
H302, H315, H319, H335Target :
Endogenous Metabolite; NF-κB; NO SynthaseType :
Natural ProductsRelated Pathways :
Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κBApplications :
COVID-19-immunoregulationField of Research :
Inflammation/ImmunologyAssay Protocol :
https://www.medchemexpress.com/SDMA.htmlConcentration :
10mMPurity :
99.00Solubility :
DMSO : 67.5 mg/mL (ultrasonic) |H2O : 50 mg/mL (ultrasonic; warming; heat to 60°C)Smiles :
N[C@@H](CCC/N=C(NC)/NC)C(O)=OMolecular Formula :
C8H18N4O2Molecular Weight :
202.25Precautions :
H302, H315, H319, H335References & Citations :
[1]Bode-Böger SM, et al. Symmetrical dimethylarginine: a new combined parameter for renal function and extent ofcoronary artery disease.|[2]Schepers E, et al. Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease.Clin J Am Soc Nephrol. 2011 Oct;6 (10) :2374-83.|[3]Nabity MB, et al. Symmetric Dimethylarginine Assay Validation, Stability, and Evaluation as a Marker for the EarlyDetection of Chronic Kidney Disease in Dogs. J Vet Intern Med. 2015 Jul-Aug;29 (4) :1036-44.|[4]Veldink H, et al. Effects of chronic SDMA infusion on glomerular filtration rate, blood pressure, myocardial function and renal histology in C57BL6/J mice. Nephrol Dial Transplant. 2013 Jun;28 (6) :1434-9.Shipping Conditions :
Room TemperatureStorage Conditions :
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category :
Natural ProductsClinical Information :
No Development ReportedIsoform :
Human Endogenous MetaboliteCAS Number :
[30344-00-4]

